Study of Pembrolizumab Following TACE in Primary Liver Carcinoma
Clinical trial NCT03397654 · COMPLETED
Trial details
- NCT number
- NCT03397654
- Sponsor
- Imperial College London
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-28
- Primary completion
- 2023-02-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.